|
|
Blood, 15 July 2007, Vol. 110, No. 2, pp. 695-708.
Prepublished online as a Blood First Edition Paper on March 27, 2007; DOI 10.1182/blood-2006-11-051672.
 Previous Article | Table of Contents | Next Article 
NEOPLASIA
Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)
Lindsay M. Morton1,
Jennifer J. Turner2,
James R. Cerhan3,
Martha S. Linet1,
Patrick A. Treseler4,
Christina A. Clarke5,
Andrew Jack6,
Wendy Cozen7,
Marc Maynadié8,
John J. Spinelli9,
Adele Seniori Costantini10,
Thomas Rüdiger11,
Aldo Scarpa12,
Tongzhang Zheng13, and
Dennis D. Weisenburger14
1 Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD;
2 Department of Anatomical Pathology, St Vincent's Hospital, New South Wales, Australia;
3 Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN;
4 Department of Pathology, University of California at San Francisco, CA;
5 Northern California Cancer Center, Fremont;
6 Haematological Malignancy Diagnostic Service, Department of Haematology, Leeds Teaching Hospital, National Health Service (NHS) Trust, Leeds, United Kingdom;
7 Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles;
8 Haematology Laboratory, University Hospital, Dijon, France;
9 British Columbia Cancer Agency, Vancouver, BC, Canada;
10 Occupational and Environmental Epidemiology Unit, Center for Study and Prevention of Cancer, Scientific Institute of Tuscany, Florence, Italy;
11 Institute of Pathology, University of Wurzburg, Germany;
12 Department of Pathology, University of Verona, Ospedale Policlinico, Verona, Italy;
13 Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT; and
14 Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha
Recent evidence suggests that there is etiologic heterogeneity among the various subtypes of lymphoid neoplasms. However, epidemiologic analyses by disease subtype have proven challenging due to the numerous clinical and pathologic schemes used to classify lymphomas and lymphoid leukemias over the last several decades. On behalf of the International Lymphoma Epidemiology Consortium (InterLymph) Pathology Working Group, we present a proposed nested classification of lymphoid neoplasms to facilitate the analysis of lymphoid neoplasm subtypes in epidemiologic research. The proposed classification is based on the World Health Organization classification of lymphoid neoplasms and the International Classification of Diseases–Oncology, Third Edition (ICD-O-3). We also provide a translation into the proposed classification from previous classifications, including the Working Formulation, Revised European-American Lymphoma (REAL) classification, and ICD-O-2. We recommend that epidemiologic studies include analyses by lymphoma subtype to the most detailed extent allowable by sample size. The standardization of groupings for epidemiologic research of lymphoma subtypes is essential for comparing subtype-specific reports in the literature, harmonizing cases within a single study diagnosed using different systems, as well as combining data from multiple studies for the purpose of pooled analysis or meta-analysis, and will probably prove to be critical for elucidating etiologies of the various lymphoid neoplasms.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
J. Kanda, K. Matsuo, T. Kawase, T. Suzuki, T. Ichinohe, M. Seto, Y. Morishima, K. Tajima, and H. Tanaka
Association of Alcohol Intake and Smoking with Malignant Lymphoma Risk in Japanese: A Hospital-Based Case-Control Study at Aichi Cancer Center
Cancer Epidemiol. Biomarkers Prev.,
September 1, 2009;
18(9):
2436 - 2441.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Vajdic, M. O. Falster, S. de Sanjose, O. Martinez-Maza, N. Becker, P. M. Bracci, M. Melbye, K. E. Smedby, E. A. Engels, J. Turner, et al.
Atopic Disease and Risk of Non-Hodgkin Lymphoma: An InterLymph Pooled Analysis
Cancer Res.,
August 15, 2009;
69(16):
6482 - 6489.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Q. Lan, L. M. Morton, B. Armstrong, P. Hartge, I. Menashe, T. Zheng, M. P. Purdue, J. R. Cerhan, Y. Zhang, A. Grulich, et al.
Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies
Blood,
July 9, 2009;
114(2):
264 - 267.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. H.M. Keegan, L. A. McClure, J. M. Foran, and C. A. Clarke
Improvements in Survival After Follicular Lymphoma by Race/Ethnicity and Socioeconomic Status: A Population-Based Study
J. Clin. Oncol.,
June 20, 2009;
27(18):
3044 - 3051.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. T. Bradford, S. S. Devesa, W. F. Anderson, and J. R. Toro
Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases
Blood,
May 21, 2009;
113(21):
5064 - 5073.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. R. Goldin, M. Bjorkholm, S. Y. Kristinsson, I. Turesson, and O. Landgren
Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia
Haematologica,
May 1, 2009;
94(5):
647 - 653.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. Morton, M. P. Purdue, T. Zheng, S. S. Wang, B. Armstrong, Y. Zhang, I. Menashe, N. Chatterjee, S. Davis, Q. Lan, et al.
Risk of Non-Hodgkin Lymphoma Associated with Germline Variation in Genes that Regulate the Cell Cycle, Apoptosis, and Lymphocyte Development
Cancer Epidemiol. Biomarkers Prev.,
April 1, 2009;
18(4):
1259 - 1270.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. P. Purdue, Q. Lan, S. S. Wang, A. Kricker, I. Menashe, T.-Z. Zheng, P. Hartge, A. E. Grulich, Y. Zhang, L. M. Morton, et al.
A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma
Carcinogenesis,
February 1, 2009;
30(2):
275 - 281.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. Morton, S. S. Wang, W. Cozen, M. S. Linet, N. Chatterjee, S. Davis, R. K. Severson, J. S. Colt, M. A. Vasef, N. Rothman, et al.
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes
Blood,
December 15, 2008;
112(13):
5150 - 5160.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. L. Edlefsen, A. De Roos, and A. LaCroix
Application of the InterLymph Consortium's Proposed Classification of Lymphoid Neoplasms for Epidemiologic Research to a Large, Nationwide Health Study: Experience in the Women's Health Initiative
Blood (ASH Annual Meeting Abstracts),
November 16, 2008;
112(11):
4669 - 4669.
[Abstract]
|
|
|
|
|
|
|
Q. Lan, U. Lim, C.-S. Liu, S. J. Weinstein, S. Chanock, M. R. Bonner, J. Virtamo, D. Albanes, and N. Rothman
A prospective study of mitochondrial DNA copy number and risk of non-Hodgkin lymphoma
Blood,
November 15, 2008;
112(10):
4247 - 4249.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Evens and B. C.-H. Chiu
The Challenges of Epidemiologic Research in Non-Hodgkin Lymphoma
JAMA,
November 5, 2008;
300(17):
2059 - 2061.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. A. Anderson, R. Pfeiffer, J. L. Warren, O. Landgren, S. Gadalla, S. I. Berndt, W. Ricker, R. Parsons, W. Wheeler, and E. A. Engels
Hematopoietic Malignancies Associated with Viral and Alcoholic Hepatitis
Cancer Epidemiol. Biomarkers Prev.,
November 1, 2008;
17(11):
3069 - 3075.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. M. Habermann, S. S. Wang, M. J. Maurer, L. M. Morton, C. F. Lynch, S. M. Ansell, P. Hartge, R. K. Severson, N. Rothman, S. Davis, et al.
Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era
Blood,
October 1, 2008;
112(7):
2694 - 2702.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. E. Khan, V. Gallo, J. Linseisen, R. Kaaks, S. Rohrmann, O. Raaschou-Nielsen, A. Tjonneland, H. E. Johnsen, K. Overvad, M. M. Bergmann, et al.
Diabetes and the risk of non-Hodgkin's lymphoma and multiple myeloma in the European Prospective Investigation into Cancer and Nutrition
Haematologica,
June 1, 2008;
93(6):
842 - 850.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Zhang, S. D. Sanjose, P. M. Bracci, L. M. Morton, R. Wang, P. Brennan, P. Hartge, P. Boffetta, N. Becker, M. Maynadie, et al.
Personal Use of Hair Dye and the Risk of Certain Subtypes of Non-Hodgkin Lymphoma
Am. J. Epidemiol.,
June 1, 2008;
167(11):
1321 - 1331.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Ekstrom Smedby, C. M. Vajdic, M. Falster, E. A. Engels, O. Martinez-Maza, J. Turner, H. Hjalgrim, P. Vineis, A. Seniori Costantini, P. M. Bracci, et al.
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium
Blood,
April 15, 2008;
111(8):
4029 - 4038.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Maskarinec, E. Erber, J. Gill, W. Cozen, and L. N. Kolonel
Overweight and Obesity at Different Times in Life as Risk Factors for Non-Hodgkin's Lymphoma: The Multiethnic Cohort
Cancer Epidemiol. Biomarkers Prev.,
January 1, 2008;
17(1):
196 - 203.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
